Abstract:Neuropeptides, functioning as peptide neurotransmitters and hormones, are generated from proneuropeptide precursors by proteolytic processing at dibasic residue sites (i.e., KR, RK, KK, RR). The cysteine proteases cathepsin L and cathepsin V, combined with the serine proteases proprotein convertases 1 and 2 (PC1/3 and PC2), participate in proneuropeptide processing to generate active neuropeptides. To compare the dibasic cleavage properties of these proteases, this study conducted global, unbiased substrate profiling of these processing proteases using a diverse peptide library in multiplex substrate profiling by mass spectrometry (MSP-MS) assays. MSP-MS utilizes a library of 228 14-mer peptides designed to contain all possible protease cleavage sites, including the dibasic residue sites of KR, RK, KK, and RR. The comprehensive MSP-MS analyses demonstrated that cathepsin L and cathepsin V cleave at the N-terminal side and between the dibasic residues (e.g., ↓K↓R, ↓R↓K, and K↓K), with a preference for hydrophobic residues at the P2 position of the cleavage site. In contrast, the serine proteases PC1/3 and PC2 displayed cleavage at the C-terminal side of dibasic residues of a few peptide substrates. Further analyses with a series of dipeptide-AMC and tripeptide-AMC substrates containing variant dibasic sites with hydrophobic P2 residues indicated the preferences of cathepsin L and cathepsin V to cleave between dibasic residue sites with preferences for flanking hydrophobic residues at the P2 position consisting of Leu, Trp, Phe, and Tyr. Such hydrophobic amino acids reside in numerous proneuropeptides such as pro-NPY and proenkephalin that are known to be processed by cathepsin L. Notably, cathepsin L displayed the highest specific activity that was 10-, 64-, and 1268-fold greater than cathepsin V, PC1/3, and PC2, respectively. Peptide-AMC substrates with dibasic residues confirmed that PC1/3 and P2 cleaved almost exclusively at the C-terminal side of dibasic residues. These data demonstrate distinct dibasic cleavage site properties and a broad range of proteolytic activities of cathepsin L and cathepsin V, compared to PC1/3 and PC2, which participate in producing neuropeptides for cell-cell communication.

Comparative Study of the Binding Pockets of Mammalian Proprotein Convertases and Its Implications for the Design of Specific Small Molecule Inhibitors

Identification of the role of a cysteine-rich region of PC6B by determining the enzymatic characteristics of its mutants

Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis

Binding of amino acid side-chains to S1 cavities of serine proteinases

Binding of amino acid side-chains to S 1 cavities of serine proteinases 1 1Edited by R. Huber

Caspase prime-side active-site characterization with non-hydrolyzable peptides assists in the design of a caspase-7-selective irreversible probe

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (Mpro) Using Hexapeptide Substrates

Study Of Inhibitors Against Sars Coronavirus By Computational Approaches

Template-assisted Rational Design of Peptide Inhibitors of Furin Using the Lysine Fragment of the Mung Bean Trypsin Inhibitor.

Modulating furin activity with designed mini-PDX peptides: synthesis and in vitro kinetic evaluation

Procleave: Predicting Protease-specific Substrate Cleavage Sites by Combining Sequence and Structural Information

Revealing Favorable and Unfavorable Residues in Cooperative Positions in Protease Cleavage Sites.

Design of Specific Serine Protease Inhibitors Based on A Versatile Peptide Scaffold: Conversion of A Urokinase Inhibitor to A Plasma Kallikrein Inhibitor

Structural Principles In The Development Of Cyclic Peptidic Enzyme Inhibitors

Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.

Functional analysis of the flexible loop of prourokinase (pro-uk) by site-directed mutagenesis

Distinct Dibasic Cleavage Specificities of Neuropeptide-Producing Cathepsin L and Cathepsin V Cysteine Proteases Compared to PC1/3 and PC2 Serine Proteases

Comprehensive protease specificity profiling

From docking to dynamics: Unveiling the potential non-peptide and non-covalent inhibitors of M pro from natural products

Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide–Protease Fusions

Binding Mechanism of Inhibitors to SARS-CoV-2 Main Protease Deciphered by Multiple Replica Molecular Dynamics Simulations.